As of April 2024 Alkermes has a market cap of $4.12 Billion. This makes Alkermes the world's 2939th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $4.12 B | -10.88% |
2023 | $4.62 B | 7.82% |
2022 | $4.29 B | 14.15% |
2021 | $3.76 B | 18.46% |
2020 | $3.17 B | -1.36% |
2019 | $3.21 B | -29.97% |
2018 | $4.59 B | -45.39% |
2017 | $8.41 B | -0.36% |
2016 | $8.44 B | -29.39% |
2015 | $11.96 B | 38.46% |
2014 | $8.63 B | 54.21% |
2013 | $5.60 B | 128.45% |
2012 | $2.45 B | 9.02% |
2011 | $2.24 B | 92.17% |
2010 | $1.17 B | 31.76% |
2009 | $0.88 B | -12.34% |
2008 | $1.01 B | -35.22% |
2007 | $1.56 B | 15.9% |
2006 | $1.34 B | -22.94% |
2005 | $1.75 B | 37.65% |
2004 | $1.27 B | 5.84% |
2003 | $1.20 B | 195.65% |
2002 | $0.40 B | -76.04% |
2001 | $1.69 B |
On Apr 25th, 2024 the market cap of Alkermes was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $353.16 B | 8,460.44% | ๐บ๐ธ USA |
Novartis NVS | $200.07 B | 4,749.59% | ๐จ๐ญ Switzerland |
Pfizer PFE | $143.91 B | 3,388.34% | ๐บ๐ธ USA |
Sanofi SNY | $122.13 B | 2,860.55% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $91.24 B | 2,111.70% | ๐บ๐ธ USA |
AstraZeneca AZN | $232.22 B | 5,528.89% | ๐ฌ๐ง UK |
Zogenix ZGNX | $1.50 B | -63.64% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | $0.82 M | -99.98% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.29 B | 270.63% | ๐ฎ๐ฑ Israel |